SCHEMBL4904359

SCHEMBL4904359

CCN(c1nc(-c2ccc(Cl)cc2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 2/20 0.40
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 4/20 0.39
TRPM8 Q7Z2W7 4/20 0.39
LMNA P02545 1/20 0.38
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
ALDH1A1 P00352 4/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.35
PTPN22 Q9Y2R2 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903647 0.92 ALDH1A1 (0.39) KDM4ERAB9ANPC1SMN1; SMN2MAPT
SCHEMBL4903806 0.91 LMNA (0.42) POLBNPC1SMN1; SMN2TRPM8LMNA
SCHEMBL4908424 0.91 LMNA (0.42) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906619 0.91 LMNA (0.40) POLBMAPTTRPM8LMNAKMT2A
SCHEMBL4901291 0.90 ALDH1A1 (0.39) KDM4ERAB9APOLBNPC1SMN1; SMN2
SCHEMBL4902506 0.90 LMNA (0.43) KDM4ERAB9APOLBNPC1SMN1; SMN2
SCHEMBL4907500 0.89 TRPM8 (0.39) KDM4ESMN1; SMN2MAPTTRPM8LMNA
SCHEMBL4901379 0.88 KDM4E (0.41) KDM4ENPC1MAPTTRPM8LMNA
SCHEMBL4904159 0.88 MEN1 (0.52) KDM4ERAB9APOLBNPC1SMN1; SMN2
SCHEMBL4903777 0.87 LMNA (0.39) POLBTRPM8LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885RAB9A 2271/4885POLB 1807/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDM4E 3834/4885RAB9A 2271/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.